Wonbiogen Co., Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was KRW 134.09 million compared to KRW 140.5 million a year ago. Net income was KRW 1,436.85 million compared to KRW 841.89 million a year ago.

Basic earnings per share from continuing operations was KRW 41 compared to KRW 23 a year ago. Diluted earnings per share from continuing operations was KRW 37 compared to KRW 23 a year ago. Basic earnings per share was KRW 41 compared to KRW 23 a year ago.

Diluted earnings per share was KRW 37.